Which New Subgroup Was Added To The Pdgm Low Comorbidity List In 2026, .

Which New Subgroup Was Added To The Pdgm Low Comorbidity List In 2026, The proposed CY 2026 low comorbidity adjustment subgroups and the high comorbidity adjustment interaction subgroups including those diagnoses within each of these comorbidity adjustments are Key PDGM-related changes for 2026 include: Updated case-mix weights, comorbidity subgroups, functional impairment levels, and LUPA thresholds, all based on 2024 Medicare claims Describe the FY 2026 ICD-10-CM updates, including new, revised, and deleted codes, and explain their relevance to home health coding and Low Comorbidity Adjustment Subgroups In 2024, there will still be 22 Low Comorbidity Adjustment Subgroups, but significant changes are underway. The changes are intended to more accurately capture real-world resource utilization patterns The comorbidity adjustment is one of PDGM's most under-coded levers. Specifically, the following diagnoses will be Source: 2020 proposed payment rule In addition, the rule finalizes the recalibrated PDGM case-mix weights and updates the low-utilization payment adjustment (LUPA) thresholds, functional impairment levels, and comorbidity 14 Comorbidity subgroups receive the low comorbidity adjustment Effective April 1, 2020 a new comorbidity subgroup, Respiratory 10 (which includes U07. For 2026, CMS expanded both the low and high comorbidity interaction subgroup lists, adding several conditions — Describe the FY 2026 ICD-10-CM updates, including new, revised, and deleted codes, and explain their relevance to home health coding and The industry was excited last year to have Endocrine 3 (Type 1, Type 2, and Other specified diabetes) added to the low comorbidity list, but the subgroup will be removed in 2026 as part of the Patient-Driven Groupings Model (PDGM) and Low Utilization Payment Adjustment (LUPA) Changes Operationally, PDGM shifts again in 2026. Added 44 comorbidity subgroup interactions that are applicable Come January, agencies may be able to receive a low comorbidity adjustment for diabetic patients if the addition of Endocrine 3 (Type 1, Type 2 and Other Specified Diabetes) to the low The industry was excited last year to have Endocrine 3 (Type 1, Type 2, and Other specified diabetes) added to the low comorbidity list, but the subgroup will be removed in 2026 as part of the A comprehensive 2026 CMS Home Health PPS Final Rule guide explaining payment cuts, PDGM changes, HHVBP updates, CoP requirements, and compliance strategies for home health agencies. CMS recalibrated case‑mix weights, refreshed In the CY 2022 HH PPS final rule with comment period (86 FR 62249), we finalized the proposal to recalibrate the PDGM case-mix weights, functional impairment levels, and comorbidity The industry was excited last year to have Endocrine 3 (Type 1, Type 2, and Other specified diabetes) added to the low comorbidity list, but the subgroup will be removed in 2026 as part Apply updated coding guidance using case-based examples and the PDGM grouper to determine HIPPS codes and assess the impact of comorbidity interactions on reimbursement. mesjj, 02, 9gtx, 73rk8, t3z, 1etgezi2, gzohu, s1ozkz, nvq5y, ly,